US Stock MarketDetailed Quotes
EYPT EyePoint Pharmaceuticals
- 11.710
- -0.160-1.35%
Trading May 8 14:53 ET
609.91MMarket Cap-6434P/E (TTM)
12.300High11.380Low887.98KVolume11.870Open11.870Pre Close10.40MTurnover2.80%Turnover RatioLossP/E (Static)52.08MShares30.99052wk High2.29P/B370.95MFloat Cap5.67052wk Low--Dividend TTM31.68MShs Float72.200Historical High--Div YieldTTM7.75%Amplitude2.190Historical Low11.708Avg Price1Lot Size
About EyePoint Pharmaceuticals Company
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Company Profile
SymbolEYPT
Company NameEyePoint Pharmaceuticals
Listing DateJan 27, 2005
Founded1987
CEODr. Jay S. Duker, M.D.
MarketNASDAQ
Employees121
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address480 Pleasant Street,Suite A-210
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-926-5000
Company Executives
- Name
- Position
- Salary
- Dr. Jay S. Duker, M.D.
- Director, President and Chief Executive Officer
- 2.92M
- Dr. Ramiro Ribeiro, M.D.,PhD
- Chief Medical Officer
- --
- George O. Elston
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 1.78M
- Dr. Goran A. Ando, M.D.
- Chairman of the Board
- 214.78K
- Nancy S. Lurker
- Executive Vice Chairman of the Board
- 3.74M
- Ye Liu
- Director
- --
- Dr. John B. Landis, PhD
- Director
- 161.67K
- Dr. David R. Guyer,M.D.
- Independent Director
- 180.67K
- Wendy F. DiCicco
- Independent Director
- 171.67K
- Dr. Anthony P. Adamis, M.D.
- Independent Director
- 146.67K
- Karen Zaderej
- Independent Director
- 149.17K
- Stuart Duty
- Independent Director
- 381.10K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg